guest ::
| Home > Publications database > Accounting for differential exclusions in the NordICC trial discloses stronger-than-reported effects of screening colonoscopy. |
| Home > Publications database > Accounting for differential exclusions in the NordICC trial discloses stronger-than-reported effects of screening colonoscopy. |
| Journal Article | DKFZ-2025-00120 |
; ; ;
2025
Elsevier Science
Amsterdam [u.a.]
This record in other databases: 
Please use a persistent id in citations: doi:10.1016/j.jclinepi.2025.111669
Abstract: Recently, results on colorectal cancer (CRC) incidence and mortality reduction by the offer of screening colonoscopy were reported for the first time from a randomized controlled trial (RCT), the Nordic-European Initiative on Colorectal Cancer (NordICC) trial. Despite randomization, there was a substantially lower proportion of post-randomization exclusions of CRC cases due to cancer registry-recorded date of diagnosis before recruitment in the invited group than in the usual-care group. We aimed to evaluate the impact of such differential exclusions on the trial's effect estimates on CRC risk.We compared reported post-randomization exclusions of CRC cases due to cancer registry-recorded date of diagnosis, and we derived adjusted effect estimates on CRC risk accounting for the reported differential post-randomization exclusion of CRC cases in the invited group and the usual-care group.Reported post-randomization exclusion proportions of CRC cases were originally reported as 52/31,472 (0.17%) and 159/63,133 (0.25%) in the invited and usual-care group (p<0.005) in an analysis including participants from all four NordICC study countries, and as 52/28,277 (0.20%) and 164/56,529 (0.29%) in the recent analysis of 10-year follow-up data from three of the countries (p=0.018). Accounting for the differential exclusion proportions increased the estimated CRC risk reduction (95% CI) from originally reported 18% (7-30%) to 25% (95% CI 13-35%) in intention-to-screen analysis. Estimated reduction of CRC risk among screening attenders increased from originally reported 31% (17-45%) to 50% (25-69%) in adjusted per-protocol analysis.Accounting for differential post-randomization exclusions of CRC cases leads to stronger-than-reported effect estimates in the so far only RCT on long-term effects of screening colonoscopy.
Keyword(s): colonoscopy ; colorectal cancer ; prevention ; randomized trial ; risk ; screening
; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; Nationallizenz
; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
